Karen Long

Karen Long is currently Sr. Director, Drug Development at InMed Pharmaceuticals, a Canadian pharmaceutical company developing topical cannabinoid therapies. She has 25 years of regulatory affairs experience in the drug and medical device industries, specializing in novel drug delivery systems such as liposomes and biodegradable polymers. Karen holds a Bachelor of Science in Chemistry and a Master's degree in Pharmaceutical Science from the University of British Columbia, and has Regulatory Affairs Certification (RAC) for United States, European, Canadian and Global regulatory affairs.